Loading MindReaderBio...
Loading MindReaderBio...
srishti gupta
Senior Analyst
Interesting as I read of all the upset about the firing of Pazdur and all the talk that FDA Commissioner Marty Makary is causing turmoil at the FDA. Last thing I heard was Pazdur overruled all the junior scientists working on the Replimune approval tanking the stock and damaging the market cap of innumerable other biotechs. Tremendous outcry from numerous melanoma specialists about the apparent arbitrary ruling.
Get crucial biotech insights delivered to your inbox.